Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
…, D Wrench, C Burney, C Knott, G Talbot… - Blood …, 2024 - ashpublications.org
During the COVID-19 pandemic, ibrutinib with or without rituximab was approved in England
for initial treatment of mantle cell lymphoma (MCL) instead of immunochemotherapy. …
for initial treatment of mantle cell lymphoma (MCL) instead of immunochemotherapy. …
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real‐world multicentre UK retrospective analysis
…, P Rakesh, B Kishore, F Karim, G Talbot… - British Journal of …, 2023 - Wiley Online Library
Daratumumab, bortezomib and dexamethasone (DVd) is approved for patients with
relapsed multiple myeloma following the CASTOR phase 3 clinical trial. This retrospective …
relapsed multiple myeloma following the CASTOR phase 3 clinical trial. This retrospective …
[HTML][HTML] Daratumumab, bortezomib and dexamethasone (DVd) at first relapse for patients with relapsed/refractory multiple myeloma (RRMM): a UK myeloma research …
…, S Hassan, G Chander, B Kishore, F Karim, G Talbot… - Blood, 2021 - Elsevier
Introduction: Daratumumab in combination with bortezomib and dexamethasone (DVd)
demonstrated a superior overall response rates (ORR) and progression free survival (PFS) …
demonstrated a superior overall response rates (ORR) and progression free survival (PFS) …
The impact of pausing Bruton tyrosine kinase inhibitor therapy and responsiveness of vaccination in blood cancer patients: primary outcome result for the randomised …
Background: Patients with CLL have profound immunosuppression, higher mortality rates
from COVID-19 infection and poorer responses to vaccination. Patients taking continuous …
from COVID-19 infection and poorer responses to vaccination. Patients taking continuous …
[HTML][HTML] A HaemSTAR-led, UK-wide 'flash-mob'audit of intravenous immunoglobulin use in immune thrombocytopenia
Methods This project aimed to audit the IVIg prescribing practices for treatment of ITP in the
UK. Data from a 5-year period between 2013 and 2018 were eligible for inclusion. The …
UK. Data from a 5-year period between 2013 and 2018 were eligible for inclusion. The …
[HTML][HTML] P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL …
…, K Ediriwickrema, C Knott, D Wrench, G Talbot… - …, 2023 - journals.lww.com
Background: Ibrutinib (IBR) is an oral covalent Bruton’s kinase inhibitor licensed for treatment
of patients (pts) with relapsed/refractory mantle cell lymphoma (MCL). During the Covid-19 …
of patients (pts) with relapsed/refractory mantle cell lymphoma (MCL). During the Covid-19 …
[HTML][HTML] Female body dissatisfaction and attentional bias to body images evaluated using visual search
One factor, believed to predict body dissatisfaction is an individual’s propensity to attend to
certain classes of human body image stimuli relative to other classes. These attentional …
certain classes of human body image stimuli relative to other classes. These attentional …
Let's learn from those who write! Using authors to engage students as readers and writers
K Talbot, G Sofatzis - Literacy Learning: The Middle Years, 2017 - search.informit.org
This article presents information about an approach one school took to engage young students
in reading and writing. It explores how professional authors inspired the students to work …
in reading and writing. It explores how professional authors inspired the students to work …
Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray
…, G Meneses-Lorente, V Bertholet, V Talbot… - Biochemical …, 2002 - Elsevier
DNA microarrays are useful tools to study changes of gene expression in response to a
treatment with drugs. Here, we describe the optimization of conditions for the cDNA synthesis …
treatment with drugs. Here, we describe the optimization of conditions for the cDNA synthesis …
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we
explored the associations between physical and psychological factors, disability, perceived …
explored the associations between physical and psychological factors, disability, perceived …